Pharma giants to unveil major $1 billion venture to push novel antibiotics

Amid escalating concerns over antibiotic resistance, several big drug makers are creating a new $1 billion for-profit venture to acquire or invest in small antibiotic companies and their nascent products, according to two people familiar with the plans.

Click HERE to see the article on STAT.